November 17, 2014

Thirty years ago, Democratic and Republican members of Congress hammered out a rare and prescient bipartisan compromise bill that transformed the pharmaceutical landscape forever and unleashed the modern generic drug industry. That law, known as the Hatch-Waxman Act, has proven to be one of the most far-reaching and impactful pieces of legislation ever to shape the American healthcare system.

November 17, 2014

Drug Store News caught up with Upsher-Smith chief commercial officer Rusty Field to discuss topiramate extended-release capsules, its new authorized generic to Qudexy XR.

November 13, 2014

Walmart Stores on Thursday reported consolidated net sales of $118.1 billion for the third quarter ended Oct. 31, representing an increase of 2.8% over last year.

 

November 7, 2014

It's one month into the cough-cold season and illness rates are up 3%, noted Matthew Mannelly, Prestige Brands president and CEO.

November 6, 2014

The NACDS-PAC supported a majority of winners in Tuesday's elections, comprising 86% in Senate races and 93% in House races, Steven Anderson, president and CEO of the National Association of Chain Drug Stores, said in a memo released Wednesday.

November 5, 2014

Walmart on Tuesday announced that Scott Price, EVP international strategy and business development, will take on additional responsibility as president and CEO, Walmart Asia.

November 4, 2014

Tailwinds from specialty pharmacy and increased generic utilization lifted CVS Health up on Tuesday, as the company posted net revenues of $35 billion, representing an increase of 9.7% for the three months ended Sept. 30.

 

October 28, 2014

Onco360, one of the nation’s largest independent providers of oncology pharmacy services, on Monday announced that Paul Jardina was named president and CEO.

October 28, 2014

Tria Beauty, a maker of at-home beauty devices, has named Peter Wyles as the company's president and CEO.

October 24, 2014

In the wake of an Oct. 21 blogpost on Health Affairs, “The $500 Billion Medicare Slowdown: A Story About Part D,” Ralph Neas, president and CEO of the Generic Pharmacuetical Association, issued the following statement.

October 23, 2014

The Partnership for Drug-Free Kids has announced that Larry Merlo, president and CEO of CVS Health, is among the new honorees for its 2014 Winter Wish Gala.

October 15, 2014

As the Food and Drug Administration begins to explore ways to improve its user-fee program for generic drugs, the Generic Pharmaceutical Association and its members have weighed in with suggestions on how to shore up the law to ensure that it helps bring generics to market faster and provides benefits across the entire healthcare system.

October 14, 2014

Twenty African-American and Hispanic community and health care organizations earlier this month submitted a letter to the Food and Drug Administration raising concerns that its Proposed Rule on Generic Labeling could jeopardize patient safety and access to affordable medicines. 

October 8, 2014

Facing a competitive landscape, Canada’s Jean Coutu Group is ramping up promotional activity and working to build loyalty among younger beauty shoppers with its private-label brand.

October 7, 2014

Following CVS Health’s bold move to stop selling tobacco products in all of its stores, president and CEO Larry Merlo, joined public health advocates and researchers on Tuesday for a roundtable discussion on tobacco sales and marketing at retail stores.

September 24, 2014

In celebration of the 30th anniversary of the enactment of the Drug Price Competition and Patent Term Restoration Act, also known as the “Hatch-Waxman” Act, the National Association of Chain Drug Stores issued a statement to reflect on the evolution of providing patient access to generic medications and noted that it is looking forward to further progress in the years ahead.

September 19, 2014

Larry Merlo, president and CEO of CVS Health, spoke on Friday before the National Press Club in Washington, D.C.

September 3, 2014

CVS Caremark announced today that it is changing its corporate name to CVS Health to reflect its broader healthcare commitment and its expertise in driving the innovations needed to shape the future of health.

September 2, 2014

ExceleraRx, a national specialty pharmacy network, last week named James Fox as its president and CEO, effective Sept. 1.

August 27, 2014

Canadian pharmaceutical company Apotex announced the appointment of Dr. Jeremy Desai to president and CEO. He has spent close to 30 years in a number of senior roles within the pharmaceutical industry and has been with Apotex for the last 11 years.

August 24, 2014

Chain pharmacy is roiling the nation’s troubled healthcare system with “disruptive innovation” and bringing new, more accessible retail health-and-wellness solutions to consumers.

August 20, 2014

Pharmacists aren’t the only professionals grappling with the uncertainties of health reform, shifting patient-care delivery models and changing reimbursement standards.

August 20, 2014

Despite a rocky start, the full rollout of health reform under the Affordable Care Act has already brought major benefits to the nation’s troubled health system and affordable coverage to millions of formerly uninsured or underinsured Americans, one of the Obama administration’s top health officials asserted recently.